Free Subscription

  • Access daily briefings and unlimited news articles

Premium

Only $34.95 per year
  • Quarterly magazine and digital
  • Indepth executive interviews
  • Unlimited news and insights
  • Expert opinion and analysis

Novartis

Novartis Archives

GSK and Novartis face penalties for misleading consumers on Voltaren products

GSK and Novartis admit that they breached Australian Consumer Law in marketing of Voltaren.

Woolworths named No. 1 in Australia for diversity and inclusion

Diageo, L'Oreal and Colgate-Palmolive are also included in the Top 25 companies.

ACCC claims ‘misleading representations’ of Voltaren products

"The alleged conduct is particularly concerning."

Novartis supports Government’s $1.8bn medicine budget commitment

It will fund new medicines on the Pharmaceutical Benefits Scheme.

Drugs giant delivers soaring results

GSK first quarter profits rocket following deal with Swiss peer Novartis.